Oliver Hasler, executive chairman of PYX Resources, presents 1H24 Results. Watch the interview here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
As nobody has made a comment regarding the delisting shortly. I have sold most of my shares in this company now ( last week ) , i did make some money in the past with this share but when they moved to the Nasdaq i think they pushed there luck too far and they slowly robbed us of our shares . You would have thought they would have just moved our shares to the US market but by not doing that they gain £ 10 million. clever. The only good point is we have been told properly by our brokers and not under the table job like Flybe RIP OFF. But they need 75 % t do that so what happens then if not passed. Any thoughts.
Just about says it all. Proposal to de-list announced on 19th December, and not a single posting here! What a pile of excrement this has turned out to be.
For every 8 it is now just one so it is actually down. ( 16.25p @ 130 )
The board of directors at Akers Biosciences Inc. said Wednesday the South Jersey medical-device company has "initiated a process to evaluate strategic alternatives to maximize shareholder value."
Based in Thorofare, Gloucester County, Akers develops and markets rapid screening and testing products for use in health care.
The board said the evaluations process will consider a range of potential strategic alternatives "including, but not limited to, business combinations." Akers said company representatives do not plan to disclose or comment on developments regarding the strategic review process until it is complete, or further disclosure is deemed appropriate.
“The board of directors and management of the company believes that now is the right time to review strategic alternatives to assess how best to maximize value for our shareholders," said Howard R. Yeaton, CEO of Akers. "During this process, the team will remain focused on advancing our current business operations and serving our customers.”
Yeaton was named CEO at Akers in October, the same month the company settled a lawsuit in part by agreeing to discontinue marketing efforts for its BreathScan OxiChek product or any product that detects oxidative stress in exhaled human breath.
The company said last month it will focus on its Particle Immuno-Filtration Assay (PIFA) technology platform that features a patented immunoassay method for rapidly and accurately detecting targeted antigens or antibodies. The technology platform is used in Akers PIFA Heparin/PF4 and PIFA Pluss/PF4 rapid assays that test for an allergic reaction to the blood-thinning medicine Heparin. These products, the company said, account for the “significant majority” of its revenues.
Akers also said Wednesday that the company to meet Nasdaq's minimum listing requirement of a minimum $1 per share stock price for companies listed on the exchange will implement a one-for-eight reverse stock split on Nov. 8.
TRENDING
BANKING & FINANCIAL SERVICES
Citizens Financial to acquire wealth management firm
As part of its continuing focus on expanding its fee product offerings, Citizens Financial Group has agreed to acquire a Westchester County, New York wealth management firm.
CAREER & WORKPLACE
Philadelphia Business Journal's Power 100, Part 5
COMING EVENT
Banking on Change: Greater Philadelphia’s Shifting Financial Landscape
Nov. 13
Its common stock will continue to trade on the Nasdaq Capital Market under the stock ticker "AKER."
Bounced up despite bad earnings .
Weird share Indeed .
Best of All
Over at other shares luckily ,will negate the continued disappointment here .
Best of All
Upwards nicely .
This company may well be very undervalued as well as under pressure from shareholders .
Best of All
Akers has took over $110million off investors for it shares and created 100s of millions of confetti shares and then it likes to consolidate them for 10 to 1 and then it looks for more money and starts creating 100s of millions of confetti shares again,,,,,,,,,, I'm one of the very few lucky investors who got out with a good profit at £2 ,,,,,, how lucky was I,,,,,,thank God it's old CEO is gone and after resigning,,,,,,you couldn't believe a word he utters,,,,,,,so be warned buy only if it's gambling money........and you believe you can trust its new CEO,,,,,,, the company is still in a mess,,,so be warned,,,and good luck ,,,,,,AIMHO,,,,,,
Optimism from the US has transferred nicely.
Quite an unforgiving spread though.
Best of All
Share Price: 10.50 Bid: 1.00 Ask: 20.00
An Interesting day ahead .
Best of All
Quite a fall from grace today . At least we remain above the 18p level . Looks to me as If 28p ask , may be back on the cards. Luckily Yiangos & I moved elsewhere . Best of All
not deramping at all but i see the old directors gone the product awaiting approval removed and a BO happaning at a massive knock down price with some huge brown envelopes to the current board only for the new company to submit the product for approval under a different name, call me synical but this stinks
Raymond F. Akers Jr., Ph.D has resigned as a director of the Company with immediate effect. Pursuant to U.S. Federal Securities Laws, within four business days the Company will file a Form 8-K with the Securities and Exchange Commission, which may include further information with respect to the resignation. The Company has decided to withdraw its initial 510(k) application for PIFA Chlamydia in order to re-evaluate its options with regards to this product development opportunity. The Company's failure to file its Form 10-Q for the quarter ended March 31, 2018 (the "Quarterly Report") constituted a delinquency under Nasdaq Listing Rule 5250(c)(1), which requires timely filing of periodic reports with the Securities and Exchange Commission ("SEC").
Yeah well the sp is not reflecting that is it?
The us market is back up
Bbr Did we get massacred ?
Good value at under 60p . Best of Luck All
Good . But not spectacular . Akers will take quite a while to reach the zenith of popularity . All things are heading in a good direction. Therefore Buy remains active . Best of Luck All
Think so too but I do think it is only a question of time before we go much higher Have you seen the post us market close? It went beyond 88 cents I think or whatever it was Looks like it’s just me and you on this board
Think we should be at 68p against US 90 cents. Best of Luck All
cant see a pullback on this - the US market is still taking this further. I reckon this goes beyond 1 dollar in the US next week.
No I dont think so cos in the US it dropped by 6%. It already dropped by this amount over here. SO this should remain stable or at least I think so. Let's see.